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Fibromyalgia syndrome (FMS) is a complex psychosomatic pain condition. In addition
to generalized pain and various cognitive difficulties, new FMS diagnostic criteria
acknowledge fatigue and sleep problems as core aspects of this condition. Indeed,
poor sleep quality has been found to be a significant predictor of pain, fatigue, and
maladaptive social functioning in this patient group. While there is promising evidence
supporting the role of mindfulness as a treatment for FMS, to date, mindfulness
intervention studies have principally focused on dimensions of pain as the primary
outcome with sleep problems either not being assessed or included as a secondary
consideration. Given the role of sleep problems in the pathogenesis of FMS, and given
that mindfulness has been shown to improve sleep problems in other clinical conditions,
the present study explored the effects of a mindfulness-based intervention known as
Flow Meditation (Meditación-Fluir) on a range of sleep-related outcomes (subjective
insomnia, sleep quality, sleepiness, and sleep impairment) in individuals with FMS.
Adult women with FMS (n = 39) were randomly assigned to the 7 weeks mindfulness
treatment or a waiting list control group. Results showed that compared to the control
group, individuals in the mindfulness group demonstrated significant improvements
across all outcome measures and that the intervention effects were maintained at
a 3 month follow-up assessment. The Meditación-Fluir program shows promise for
alleviating sleep problems relating to FMS and may thus have a role in the treatment
of FMS as well as other pain disorders in which sleep impairment is a central feature of
the condition.
Keywords: fibromyalgia syndrome, mindfulness, sleep disorders, sleep quality, second-generation mindfulness-
based interventions
INTRODUCTION
Fibromyalgia syndrome (FMS) is a chronic pain condition characterized by localized pain spots as
well as prolonged generalized body pain. Other typical symptoms include fatigue, trouble sleeping,
headaches, numbness in the hands and feet, depression, anxiety and decreased tolerance to exercise
(Staud et al., 2001; Costa et al., 2017; Sosa-Reina et al., 2017). FMS affects around 3% of the general
population, with a seven-to-one higher prevalence in women aged 20–50 years old versus men
of the same age (Prados and Miró, 2012; Lauche et al., 2013; Feliu-Soler et al., 2016). Studies
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demonstrate a deterioration in quality of life in individuals
suffering from FMS compared to those with other rheumatic
or autoimmune diseases (Hoffman and Dukes, 2008; González
et al., 2010). FMS has a strong negative impact on family and
social engagement and imposes substantial healthcare and social
services costs (Rivera et al., 2006; Langhorst et al., 2013; Van
Gordon et al., 2016).
In 2010, the American College of Rheumatology proposed a
new set of diagnostic criteria for FMS replacing the traditional
1990 classification (Wolfe et al., 1990). In addition to including
generalized pain and various cognitive difficulties, the new
criteria acknowledged fatigue and sleep problems as core aspects
of the condition (Wolfe et al., 2010; Schmidt et al., 2011).
Research has shown that sleep impairment can lower the
threshold for pain as well as trigger musculoskeletal pain and
emotional distress (Prados and Miró, 2012; Becker et al., 2018).
Indeed, in a study of 101 FMS patients, 99% exhibited poor
sleep quality that was found to be a significant predictor of
pain, fatigue, and maladaptive social functioning (Miró et al.,
2011). Research also shows that sleep quality moderates the
relationship between affect and pain in patients with FMS, and
that a high quality of sleep thus increases patients’ tolerance to
pain episodes. Similarly, it has been shown that sleep quality
is a significant mediator in the relationship between pain and
anxiety or depression in FMS patients (Miró et al., 2011; Li et al.,
2018). Furthermore, both poor quality sleep and pain can elicit
catastrophizing thought and behavior patterns which in turn lead
to the impairment of pain coping cognitive strategies (Prados
and Miró, 2012; Di Tella et al., 2018). Thus, sleep problems play
an important role in the exacerbation of FMS symptoms and
increase the likelihood of both depression and impaired physical
and psychological functioning in this patient group (Bigatti et al.,
2008; González et al., 2010; Finan et al., 2013; Galvez-Sánchez
et al., 2018).
Recommended treatments for FMS include anti-
inflammatories and antidepressants as well as other medication
to target mechanisms of pain (Crofford and Appleton, 2000;
Crofford, 2008). However, sleep disturbances are one of the
most common residual symptoms of antidepressant medication
(ADM), and are associated with (amongst other things)
exacerbating and perpetuating mood disturbance, poor quality
of life, and reductions in mindfulness levels in FMS patients
(Modrego et al., 2016; Li et al., 2018). In addition, sleep studies
using polysomnography have shown that ADMs can disrupt
sleep continuity and increase the number of awakenings during
periods of sleep (Britton et al., 2012).
Consequently, more effective treatment strategies for FMS
are likely those that use pharmacotherapy in moderation and
integrate non-pharmacological approaches such as mindfulness,
relaxation therapy, cognitive-behavioral therapy, physical
exercise, and/or psycho-education (Glombiewski et al., 2010;
Parra and Latorre, 2013; Van Gordon et al., 2016). Given the
importance of sleep in the physiopathology of fibromyalgia,
mindfulness in particular warrants further investigation because:
(i) it has been shown to improve sleep quality in a range
of pathologies (Shonin et al., 2015), and (ii) improvements
in quality of life in individuals with FMS after receiving a
mindfulness-based intervention known as Meditation Awareness
Training (MAT) appear to be linked to increases in sleep quality
(Van Gordon et al., 2016, 2017). Furthermore, mindfulness has
also been shown to be beneficial in targeting certain symptoms
of FMS, such as depression, anxiety, anger, and poor quality of
life (Grossman et al., 2007; Sephton et al., 2007; Schmidt et al.,
2011; Amutio et al., 2015a; Kanen et al., 2015). In line with
these findings, a correlational study of FMS patients (n = 4,986)
showed that trait mindfulness was negatively associated with
symptom severity (Jones et al., 2015). However, despite these
promising findings, to date studies evaluating the effectiveness
of mindfulness as a treatment for FMS have principally focused
on dimensions of pain as the primary outcome with sleep
problems either not being assessed or included as a secondary
consideration in conjunction with other outcomes relevant to
the condition (Schmidt et al., 2011; Cash et al., 2015; Martínez
et al., 2016).
Given the role of sleep problems in the pathogenesis of
FMS, the lack of conclusive data for extant pharmacological
and non-pharmacological FMS treatments, and the fact that
mindfulness has been shown to improve sleep problems and
fatigue in various other clinical and non-clinical conditions
(Britton et al., 2012; Rimes and Wingrove, 2013; Hülsheger et al.,
2015; Kanen et al., 2015), there is a need to specifically assess
the effects of mindfulness on a range of sleep-related outcomes
in individuals with FMS. Thus, the purpose of the present study
was to evaluate the effects of a mindfulness-based intervention
known as Meditación- Fluir -Flow Meditation – (Franco, 2009)
on subjective insomnia, sleep quality, sleepiness, and sleep
impairment in individuals with FMS. It was hypothesized that
compared to a waitlist control group, individuals with FMS
that completed the mindfulness intervention would demonstrate
significant improvements in the aforementioned variables.
MATERIALS AND METHODS
A randomized controlled trial was conducted to investigate the
effects of mindfulness training on subjective insomnia, sleep
quality, sleepiness, and sleep impairment in individuals with
FMS. Assessments were taken at pre-test, post-test, and 3 month
follow-up phases and the intervention group was compared with
a waiting list control group.
Participants
To be eligible for the study, participants had to be: (i) able to
prove a current diagnosis of FMS (e.g., via a letter from a doctor
of pain consultant), (ii) female, (iii) aged 18–70 years, and (iv)
not currently undergoing mindfulness training and/or formal
psychotherapy (stable prescription medication was permitted
for both the intervention and control group). All participants
were recruited from the Asociación de Fibromialgia de Almería
(AFIAL) and were informed that they would be undertaking
a program of training in mindfulness for individuals with
FMS. A total of 39 eligible individuals were recruited into
the study and random assignment was employed to allocate
participants to the intervention (n = 20) or control group
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(n = 19). More specifically, ballots, concealing the numbers
1 (control group) or 2 (intervention group), were placed in
equal number into an urn and each participant extracted one
ballot from it. Randomization was conducted by a researcher
not participating in the study and participants completed
baseline assessments prior to allocation. Due to a logistical
constraint, a sample size calculation was not conducted because
sample size was governed by the maximum number of eligible
female participants – based at the aforementioned regional FMS
association – that were willing to participate in the study at the
time of enrolment.
Procedure
A mindfulness training program called Flow Meditation
(Meditación-Fluir – Franco, 2009) was administered to
the intervention group using 2 h weekly group sessions
for a period of 7 weeks. The training program included:
(i) mindfulness exercises from Kabat-Zinn’s (1990) stress-
reduction program, (ii) mindfulness techniques used in
acceptance and commitment therapy (Hayes et al., 1999;
Wilson and Luciano, 2002; Carrascoso, 2006), and (iii)
exposure to and debate on metaphors and exercises used
in Zen (Deshimaru, 2006) and Vipassana meditation (Hart,
1994) which promote values such as acceptance, forgiveness,
and non-identification with mental events. The effectiveness
of Meditación-Fluir has been tested in various treatment
studies with acceptable size effects (Amutio et al., 2015a;
Franco et al., 2017, 2016). The program includes existential,
ethical, and spiritual aspects and values, and thus conforms
to Van Gordon et al.’s (2015) criteria for Second Generation
Mindfulness-Based Interventions (SG-MBIs). The program
was facilitated by an instructor with extensive experience in
both the practice and teaching of mindfulness meditation
techniques.
The main purpose of Meditación-Fluir is for participants to
learn to allow their thoughts to flow, without trying to modify
them or interfere with them. The intervention is not concerned
with teaching participants not to think about anything, but seeks
to offer an alternative to conditioned automatic ways of reacting
to inner and outer experiences. Each weekly session is structured
as follows:
(1) Discussion and feedback on the mindfulness meditation
exercises practiced during the previous week.
(2) Ten minutes guided mindful body-scan.
(3) Presentation of the various metaphors and exercises
corresponding to each session.
(4) Practice of full awareness of breathing for 30 min.
Both during the active treatment and follow-up phases,
participants were requested to undertake mindful body-scan and
full awareness of breathing exercises on a daily basis at home for
10 and 30 min, respectively. Furthermore, participants were also
asked to keep a daily record of their level of engagement with at-
home practices by means of a register sheet especially designed
for this purpose.
Ethical Considerations
All participants provided informed consent and the study was
approved by the Bioethics Committee of the University of
Almeria, Spain. The registered data for each of the instruments
was alphanumerically coded, ensuring confidentiality and
anonymity, in order to comply with the Personal Data Protection
Act by the Ethics Committee for Research related to Human
Beings (CEISH). International guidelines for studies with human
subjects described in the Nuremberg Code and in the Declaration
of Helsinki were applied. After completion of all assessment
phases, the mindfulness training course was offered to control
group participants.
Measures
The following measures were administered pre- and post-
intervention and at 3 months after the final group session in week
seven:
(i) Athens Insomnia Scale (Soldatos et al., 2000). This scale
enables the subjective presence of insomnia to be identified
based on the diagnostic criteria of the Classification of
Mental and Behavioral Disorders (ICD-10). The scale
comprises eight items and the first five items evaluate
difficulty inducing sleep, waking up at night, waking up
early, and total sleep quality. The last three items explore
the daytime consequences of sleep problems including
sleepiness, reduced well-being and poor functioning.
Higher scores correspond to more severe sleep impairment
and a score over five indicates the presence of insomnia. In
the present study, the Spanish-validated version of the scale
was utilized (Nenclares and Jiménez, 2005). The scale had
a Cronbach’s alpha of 0.90 in the present sample of FMS
patients.
(ii) Pittsburgh Sleep Quality Index (Buysse et al., 1989). This
scale consists of 19 items that are scored on a four-point
Likert scale. Scale items assess subjective sleep quality in
the past month based on seven components: subjective
sleep quality, sleep latency, sleep duration, habitual sleep
efficiency, extrinsic sleep disturbances, use of sleeping
(hypnotic) medication, and daytime dysfunction. Each
component is scored from 0 to 3 and higher scores indicate
a greater degree of sleep impairment. The scale showed an
internal consistency of 0.83 in the current study sample,
who were administered the Spanish-validated version of the
scale (Royuela and Macías, 1997).
(iii) Epworth Sleepiness Scale (Johns, 1991). This scale estimates
subjective daytime sleepiness and comprises eight items.
The scale assesses sleepiness in different daily situations
and each item receives a score of 0–3 points. The Spanish-
validated version of the scale (Chica et al., 2007) was used
in the current study and the Cronbach’s alpha was 0.85.
(iv) Sleep Impairment Index (Morin, 1993). This scale comprises
seven items that evaluate the subjective perception of the
symptoms and consequences of insomnia, as well as how
much the respondent is worried about these problems.
Each of the seven items are scored on a four-point Likert
scale and the total score ranges from 0 to 28. Higher
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scores indicate more severe insomnia. The scale showed
a Cronbach’s alpha of 0.79 for the present sample of
FMS patients that were administered the Spanish-validated
version of the scale (Morin, 1998).
Data Analyses
Due to the fact the data did not fit to a normal probability
distribution, the Mann–Whitney U-test for independent samples
was used to check for statistically significant differences in mean
scores between allocation conditions. To test for statistically
significant within-group differences between assessment phases,
the Friedman test for k related samples was used and where
the outcome was significant, the Wilcoxon test was subsequently
employed. Bonferroni corrections were applied to lower the
probability of finding a false significant difference due to
chance. Cohen’s d and the percentage change between pre-
test and post-test, as well as pre-test and follow-up scores
were used to evaluate the magnitude of the change (where
d = 1.5 or above reflects a very large effect-size, d = 1.5–1
reflects a large effect-size, and d = 1–0.5 reflects a medium





All participants were aged between 39 and 66 years (M = 51.8;
SD = 10.2). A total of 8% of participants had no formal
education, 62% had a primary-school education, 16% had
intermediate studies education and 14% had a higher education.
In terms of relationship status, 76% of participants were
married, 14% were single, 3% were separated and 7% were
widowed. All participants attended all assessment phases (i.e.,
there was no-missing data) and in respect of the at-home
practice, the average rate of compliance was 71% for the body-
scan exercise and 83% for the full awareness of breathing
exercise.
Intervention Effects
Means and standard deviations for each outcome measure for
intervention and control group at all assessment phases are
shown in Table 1.
No significant baseline differences were observed between
median scores for the intervention and control groups for any
of the outcome measures. However, a significant difference was
observed between groups at post-test for subjective insomnia,
sleep quality, sleepiness, and sleep impairment. Furthermore,
significant between group differences were observed at follow-
up for subjective insomnia, sleep quality, sleepiness, and sleep
impairment (see Table 2).
The Friedman test and follow-up Wilcoxon test showed that
there were significant improvements across all outcome variables
for the experimental group between pre-test and post-test,
and between pre-test and follow-up. However, no significant
difference was observed between post-test and follow-up for
any of the outcome measures, suggesting that the reductions
in sleep quality were maintained following conclusion of the
mindfulness training (see Tables 3, 4). No significant within-
group differences were observed for the control group between
any of the assessment phases.
Table 5 shows the effect size and percentage change between
assessment phases for the intervention group. The pre-test to
post-test change in the intervention group was of a large effect
size for sleep quality (d = 1.07) and sleepiness (d = 1.02),
and a medium effect size for sleep impairment (d = 0.93) and
subjective insomnia (d = 0.84). For the change between pre-test
and follow-up, medium effect-sizes were observed for sleepiness
(d = 0.79), sleep quality (d = 0.76), sleep impairment (d = 0.71),
and subjective insomnia (d = 0.65). Percentages of change in
the aforementioned variables after the intervention were also
important, ranging from 20 to 30% in the post-test phase, and
from 17 to 20% at follow-up.
DISCUSSION
The current study compared an SG-MBI known as Flow
Meditation (Meditación-Fluir) with a waiting list control group
TABLE 1 | Means and standard deviations for each outcome measure at pre-test, post-test, and 3 month follow-up.
Variables Pre-test Post-test Follow-up
M SD M SD M SD
Control Group
Subjective insomnia 14.2 4.7 14.7 4.7 13.9 3.9
Sleep quality 12.4 3.1 13.1 3.3 12.8 3.6
Sleepiness 15.6 3.4 15.9 4.6 16.1 4.4
Sleep impairment 16.9 5.9 17.2 5.8 16.3 6.1
Intervention Group
Subjective insomnia 14.8 4.4 11.4 3.7 12.23 3.4
Sleep quality 13.0 3.9 9.1 3.3 10.37 3.1
Sleepiness 16.2 3.1 12.9 3.3 13.45 3.7
Sleep impairment 16.1 4.2 12.5 3.2 13.09 4.1
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TABLE 2 | Pre-test, post-test, and follow-up between-group differences for all outcome measures.
Variables Pre-test Post-test Follow-up
z p z p z p
Subjective insomnia 0.49 0.53 3.9 0.005∗∗ 2.9 0.009∗
Sleep quality 0.32 0.64 4.0 0.005∗∗ 3.4 0.006∗
Sleepiness 0.41 0.57 3.8 0.006∗ 3.3 0.006∗
Sleep impairment 0.34 0.61 5.1 0.001∗∗∗ 4.0 0.005∗∗
∗∗∗p = 0.001; ∗∗p = 0.005; ∗p < 0.01.
TABLE 3 | Friedman test for k related samples for each study variable in the
intervention and control groups.
Group Control Intervention
Variables χ2 P χ2 P
Subjective insomnia 1.3 0.51 10.7 0.008∗
Sleep quality 2.3 0.45 11.4 0.006∗
Sleepiness 1.9 0.48 12.7 0.003∗∗
Sleep impairment 2.9 0.39 13.4 0.001∗∗∗
∗∗∗p = 0.001; ∗∗p < 0.005; ∗p < 0.01.
to investigate the effects of mindfulness on sleep problems in
female adults with FMS. Results showed that compared to the
control condition, the mindfulness intervention was effective in
reducing insomnia and improving sleep quality. To the authors’
knowledge, this is the first study to specifically investigate the
effects of mindfulness on a range of sleep-related outcomes in
individuals with FMS.
These findings are consistent with studies showing
improvements in the number of hours of sleep in patients with
depression after 8 weeks of mindfulness training (Britton et al.,
2012; Kanen et al., 2015). Findings are also in line with studies
demonstrating a reduction in general FMS symptomatology
following mindfulness training (Schmidt et al., 2011; Langhorst
et al., 2013; Parra and Latorre, 2013; Amutio et al., 2015a).
Furthermore, findings are consistent with mindfulness studies
focussing on conditions other than FMS that have shown
reductions in pain-related psychological effects including sleep
quality (Carlson et al., 2003; Day et al., 2012; Goyal et al., 2014;
Henke and Chur-Hansen, 2014).
However, it should be noted that some studies of mindfulness
(e.g., using mindfulness-based stress reduction – MBSR) have
TABLE 5 | Cohen’s d and percentage change in pre-test to post-test and pre-test
to follow-up in study variables in the intervention group.
Variable d Post-test d Follow-up % Post-test % Follow-up
Subjective
insomnia
0.8 0.65 −22.8 −17.4
Sleep
quality
1.1 0.76 −29.7 −20.4
Sleepiness 1.0 0.79 −20.2 −16.9
Sleep
impairment
0.93 0.71 −21.9 −18.4
not demonstrated short-or long-term significant effects on sleep
quality (Lauche et al., 2013). One possible explanation for
this is that in the present study, sleep quality was thoroughly
assessed via a battery of different sleep-relevant assessment
tools that were able to capture a broader range of changes
in overall sleep quality. A further explanation is that unlike
MBSR that belongs to the first-generation of mindfulness
approaches, the present study employed a mindfulness approach
named Meditación-Fluir (Flow Meditation) that corresponds
to a Second-Generation Mindfulness-Based Interventions (SG-
MBIs; Van Gordon et al., 2016, 2017). Compared to first-
generation mindfulness-based interventions, SG-MBIs employ
a slightly different model of mindfulness that emphases
the importance of non-attachment to self as well as to
psychological and somatic symptoms (Van Gordon et al.,
2015).
Although there is mixed-evidence and continued debate as
to whether mindfulness decreases pain and improves quality of
life in FMS patients (Schmidt et al., 2011; Henke and Chur-
Hansen, 2014; Hervás et al., 2016), results of the present study
offer additional support for the use of mindfulness to treat sleep
TABLE 4 | Wilcoxon test for related samples of the pre-test to post-test, pre-test to follow-up, and post-test to follow-up differences in the study variables in the
intervention group.
Variables Pre–Post Pre–Follow-up Post–Follow-up
z P z p z P
Subjective insomnia 4.4 0.000∗∗∗∗ 3.9 0.005∗∗ 0.29 0.687
Sleep quality 5.1 0.000∗∗∗∗ 3.6 0.007∗ 0.57 0.416
Sleepiness 4.2 0.001∗∗∗ 3.6 0.008∗ 0.32 0.631
Sleep impairment 4.1 0.001∗∗∗ 3.8 0.005∗∗ 0.43 0.529
∗∗∗∗p < 0.001; ∗∗∗p = 0.001; ∗∗p = 0.005; ∗p < 0.01.
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problems in this patient group. In terms of possible mechanisms
of action, poor sleep quality in individuals with FMS has been
shown to negatively influence the regulation of emotion (Britton
et al., 2012; Larson and Carter, 2016). Furthermore, abnormal
sympathetic nervous system reactivity in patients with FMS is
associated with variability in cardiac frequency during sleep
(Prados and Miró, 2012). Additionally, pre-sleep arousal has also
been found to be a partial mediator in the relationship between
mindfulness and reported level of rest during sleep (Li et al.,
2018). Therefore, in the present study, in addition to decreased
hyperarousal of the sympathetic nervous system and increases
in parasympathetic activation through relaxation, mindfulness
may have improved sleep quality via the cultivation of new
metacognitive resources (e.g., detachment from self-referential
processing and acceptance) that increase perceptual distance
from painful and/or distressing sensory and psychological stimuli
(Lauche et al., 2013; Labelle et al., 2015; Van Gordon et al., 2016,
2017; Franco et al., 2017; Wheeler et al., 2017).
This is consistent with previous studies of Meditación-Fluir in
which mindfulness was shown to improve state and trait anxiety,
depression, and anger regulation in FMS patients (Amutio et al.,
2015a) and in other populations including adolescents with high
levels of aggressiveness and lack of impulse control (Franco et al.,
2016) and older adults with high levels of anxiety, depression, and
worry (Franco et al., 2017). These previous findings concerning
improvements in anger regulation are particularly relevant since
the use of adaptive coping strategies to recognize and express
emotions has been associated with reduced burden of FMS
(Castelli et al., 2012; Geenen et al., 2012; Sancassiani et al., 2017;
Di Tella et al., 2018).
The beneficial outcomes observed in the present study were
maintained for a minimum of 3 months. Similar maintenance
effects have also been observed in other studies of mindfulness
involving patients with FMS (Grossman et al., 2007; Amutio
et al., 2015a; Cash et al., 2015; Van Gordon et al., 2017),
as well as in studies following a similar approach to the
model of mindfulness training adopted by the Meditación-Fluir
intervention used in the present study (Amutio et al., 2015a;
Franco et al., 2017). Some plausible explanations as to why
the effects of mindfulness training programs are frequently
maintained at follow-up assessments is that mindfulness is a
technique that enhances positive affect and that it is relatively
easy to integrate into daily life (Davis and Zautra, 2013; Amutio
et al., 2015b; Galvez-Sánchez et al., 2018). This is an important
consideration for patients with FMS that due to pain-related
concentration deficits can experience difficulties in adapting to
new psychological strategies (Schmidt et al., 2011; Van Gordon
et al., 2016).
The findings of the present study should be considered in
light of their limitations that include: (i) a small sample size, (ii)
the absence of an active control condition, and (iii) reliance on
self-report measures. Furthermore, although the study included
a 3 month follow-up assessment, it would be useful to investigate
maintenance effects over a longer period of time.
Fibromyalgia syndrome is a complex, multifaceted condition,
which means that it is difficult to determine the precise
components and functional mechanisms of mindfulness that are
most active during its treatment. However, given the association
between sleep quality and FMS symptomatology, and given
the body of evidence suggesting that mindfulness can improve
sleep quality in both clinical and non-clinical samples, it is
reasonable to assume that improvements in sleep quality elicited
through mindfulness play an important role in ameliorating
symptomatology in individuals with FMS. This is in line with
findings from this study, as well as with calls for FMS treatments
that acknowledge the role of sleep problems in FMS and thus seek
to directly alleviate this aspect of the condition (Theadom et al.,
2007; Prados and Miró, 2012; Adler-Neal and Zeidan, 2017; Li
et al., 2018).
The current study showed that a SG-MBI known as
Meditación-Fluir was effective for reducing sleep problems in
adults with FMS. While pharmacological treatments may lead to
symptom reduction in FMS patients, some of these medications
can cause disruptions in the physiology of sleep leading to
adverse effects such as dizziness, headaches, and sleepiness
(Britton et al., 2012; Prados and Miró, 2012). Consequently, non-
pharmacological treatments, such as mindfulness, that helps to
regulate and improve sleep quality, appear to have a role in the
treatment of FMS. Thus, further research is warranted to replicate
the findings of this study as well as understand the mechanisms
that lead to improvements in sleep quality following participation
in mindfulness training by individuals with FMS.
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